Literature DB >> 2448095

Ultrasonography and alpha-fetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis.

A Maringhini1, M Cottone, E Sciarrino, M P Marcenó, F La Seta, G Fusco, F Rinaldi, L Pagliaro.   

Abstract

The accuracy of ultrasound (US) and alpha-fetoprotein (AFP) in the diagnosis of hepatocellular carcinoma (HCC) in 363 patients with cirrhosis (C) and a clinical suspicion of HCC was assessed. The ultrasonographic patterns of HCC and their relationship with AFP values were analyzed. Echographic patterns were distributed as follows: 47 patients had sonodense lesions; 30 patients had hypoechoic lesions; 47 had mixed-pattern lesions, and in four patients focal dilated intrahepatic bile ducts were demonstrated. The sensitivity of US was 90%; specificity was 93.3%. Serum AFP level greater than or equal to 500 ng/ml (RIA) was the first clue to the diagnosis in 71 patients (48.6%); specificity was 100%. In 28 patients AFP levels became significantly elevated during follow-up after US detection of HCC. No relationship between echo pattern and serum AFP levels was demonstrated. An algorithm for diagnosis of HCC is proposed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2448095     DOI: 10.1007/bf01536630

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Serum alpha-fetoprotein in nonneoplastic liver diseases.

Authors:  J R Bloomer
Journal:  Dig Dis Sci       Date:  1980-04       Impact factor: 3.199

2.  Ultrasonographic and radionuclide detection of hepatocellular carcinoma in cirrhotics with low alpha-fetoprotein levels.

Authors:  A Maringhini; M Cottone; E Sciarrino; M P Marcenò; F La Seta; F Rinaldi; L Pagliaro
Journal:  Cancer       Date:  1984-12-15       Impact factor: 6.860

3.  Small hepatocellular carcinoma--a clinicopathological study in thirteen patients.

Authors:  D S Chen; J C Sheu; J L Sung; M Y Lai; C S Lee; C T Su; Y M Tsang; S W How; T H Wang; J Y Yu; T H Yang; C Y Wang; C Y Hsu
Journal:  Gastroenterology       Date:  1982-11       Impact factor: 22.682

4.  Cytologic diagnosis of hepatocellular carcinoma by fine-needle aspiration biopsy.

Authors:  L C Tao; C S Ho; M J McLoughlin; W K Evans; E E Donat
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

Review 5.  Natural history of primary and secondary tumors of the liver.

Authors:  B Cady
Journal:  Semin Oncol       Date:  1983-06       Impact factor: 4.929

6.  Echographic and radionuclide detection of hepatoma.

Authors:  T W Broderick; B Gosink; L Menuck; R Harris; J Wilcox
Journal:  Radiology       Date:  1980-04       Impact factor: 11.105

7.  Ultrasound manifestations of hepatocellular carcinoma.

Authors:  P D Kamin; M E Bernardino; B Green
Journal:  Radiology       Date:  1979-05       Impact factor: 11.105

8.  Clinical classification of hepatoma in Japan according to serial changes in serum alpha-fetoprotein levels.

Authors:  Y Matsumoto; T Suzuki; I Asada; K Ozawa; T Tobe; I Honjo
Journal:  Cancer       Date:  1982-01-15       Impact factor: 6.860

9.  Diagnosis and screening of small hepatocellular carcinomas. Comparison of radionuclide imaging, ultrasound, computed tomography, hepatic angiography, and alpha 1-fetoprotein assay.

Authors:  T Takashima; O Matsui; M Suzuki; M Ida
Journal:  Radiology       Date:  1982-12       Impact factor: 11.105

10.  Alpha-fetoprotein (AFP) in benign liver disease. Evidence that normal liver regeneration does not induce AFP synthesis.

Authors:  E Alpert; E R Feller
Journal:  Gastroenterology       Date:  1978-05       Impact factor: 22.682

View more
  17 in total

1.  Focal ultrasound lesions in liver cirrhosis diagnosed as regenerating nodules by fine-needle biopsy. Follow-up of 12 cases.

Authors:  G L Rapaccini; M Pompili; E Caturelli; M Anti; A Aliotta; A Cedrone; E Amadei; A Grattagliano; M M Squillante; C Rabitti
Journal:  Dig Dis Sci       Date:  1990-04       Impact factor: 3.199

2.  Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis.

Authors:  F Izzo; F Cremona; F Ruffolo; R Palaia; V Parisi; S A Curley
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

Review 3.  Screening for hepatocellular carcinoma. Review and perspective.

Authors:  J C Ellis
Journal:  West J Med       Date:  1988-08

Review 4.  Preventive care in chronic liver disease.

Authors:  T R Riley; J P Smith
Journal:  J Gen Intern Med       Date:  1999-11       Impact factor: 5.128

5.  Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.

Authors:  Ryosuke Tateishi; Haruhiko Yoshida; Yutaka Matsuyama; Norio Mine; Yuji Kondo; Masao Omata
Journal:  Hepatol Int       Date:  2007-12-29       Impact factor: 6.047

6.  Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

Authors:  Masao Omata; Laurentius A Lesmana; Ryosuke Tateishi; Pei-Jer Chen; Shi-Ming Lin; Haruhiko Yoshida; Masatoshi Kudo; Jeong Min Lee; Byung Ihn Choi; Ronnie T P Poon; Shuichiro Shiina; Ann Lii Cheng; Ji-Dong Jia; Shuntaro Obi; Kwang Hyub Han; Wasim Jafri; Pierce Chow; Seng Gee Lim; Yogesh K Chawla; Unggul Budihusodo; Rino A Gani; C Rinaldi Lesmana; Terawan Agus Putranto; Yun Fan Liaw; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2010-03-18       Impact factor: 6.047

7.  Positive status of alpha-fetoprotein and des-gamma-carboxy prothrombin: important prognostic factor for recurrent hepatocellular carcinoma.

Authors:  Masaki Kaibori; Yoichi Matsui; Hidesuke Yanagida; Norio Yokoigawa; A-Hon Kwon; Yasuo Kamiyama
Journal:  World J Surg       Date:  2004-06-08       Impact factor: 3.352

8.  Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.

Authors:  Duo Zuo; Liwei Chen; Xiaoqian Liu; Xia Wang; Qing Xi; Yi Luo; Ning Zhang; Hua Guo
Journal:  Tumour Biol       Date:  2015-12-04

9.  Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer.

Authors:  S A Curley; F Izzo; A Gallipoli; M de Bellis; F Cremona; V Parisi
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

10.  The Evolution of the Use of Serum Alpha-fetoprotein in Clinical Liver Cancer Surveillance.

Authors:  Sarah-Louise Kelly; Thomas G Bird
Journal:  J Immunobiol       Date:  2016-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.